When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?-a critical review of LITESPARK-004 results.
作者信息
Sener Ugur, Galloway Taylor
机构信息
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
出版信息
Transl Cancer Res. 2025 May 30;14(5):2558-2562. doi: 10.21037/tcr-2024-2478. Epub 2025 May 13.
Abstract
摘要
Zotero 插件